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Methionine metabolism in an animal model of sepsis
Abstract
Background: Sepsis is a disease with high incidence and lethality and is accompanied by profound
metabolic disturbances. In mammalian methionine metabolism, S-adenosylmethionine (SAM) is
produced, which is important in the synthesis of neurotransmitters and glutathione and as an
anti-inflammatory agent. The degradation product and antagonist of SAM is S-adenosylhomocysteine
(SAH). In this study, we investigated changes in methionine metabolism in a rodent model of sepsis.
Methods: Sepsis was induced in male Wistar rats (n=21) by intraperitoneal injection of bacterial
lipopolysaccharide (10 mg/kg). Controls (n=18) received vehicle only. Blood was collected by cardiac
puncture 24 h later. Puncture of the suboccipital fossa was performed to collect cerebrospinal fluid
(CSF). Methionine metabolites were measured using stable isotope dilution tandem mass spectrometry.
Plasma total homocysteine and cysteine were measured by HPLC using fluorescence detection.
Glutathione was assayed using a modified enzymatic microtiter plate assay. Results: We observed
significantly higher plasma levels of SAM (p<0.001) and SAM/SAH ratio (p=0.004) in septic animals.
In CSF, there was also a trend for higher levels of SAM in septic animals (p=0.067). Oxidative stress
was reflected by an increase in the ratio of oxidized/reduced glutathione in septic animals (p=0.001).
Conclusions: Sepsis is associated with an increase in SAM/SAH ratio in plasma and CSF in rodents.
This indicates an altered methylation potential during sepsis, which may be relevant for
sepsis-associated impairment of transmethylation reactions, circulation and defense against oxidative
stress. If verified in humans, such findings could lead to novel strategies for supportive treatment of
sepsis, as methionine metabolism can easily be manipulated by dietary strategies.
Methionine metabolism in an animal model of sepsis 
 
 
Alexander Semmler1,2, Yvo Smulders3,  Eduard Struys4, Desiree Smith3, Susanna Moskau1, 
Henk Blom3, Michael Linnebank1,2 
 
 
1University Hospital Zurich, Department Neurology, Switzerland 
2University Hospital Bonn, Department Neurology, Germany 
3VU University Medical Center, Department Internal Medicine and Institute for 
Cardiovascular Research-ICaR-VU, Amsterdam, The Netherlands 
4VU University Medical Centre, Metabolic Unit, Department of Clinical Chemistry, De 
Boelelaan 1117, 1081 HV Amsterdam, The Netherlands 
 
Correspondence: Dr. Alexander Semmler, University Hospital Bonn, Sigmund-Freud-Str. 25, 
D-53125 Bonn, Germany. Phone: +49 228 287-15712. Fax: +49 228 287-15455. E-mail: 
alexander.semmler@ukb.uni-bonn.de 
 
 
 
Running title: Methionine metabolism in sepsis 
 
 2
Abstract 
Background: Sepsis is a disease with a high incidence and a high lethality. Sepsis is 
accompanied by profound metabolic disturbances. In mammalian methionine metabolism, S-
adenosylmethionine (SAM) is produced, which is important for the synthesis, e.g., of 
neurotransmitters and glutathione, and SAM acts as an anti-inflammatory agent. Degradation 
product and antagonist of SAM is S-adenosylhomocysteine (SAH). This study investigated 
changes in this metabolism during sepsis in a rodent model. 
Methods: Sepsis was induced in Male Wistar rats (n=21) by an intraperitoneal injection of 
bacterial lipopolysaccharide (LPS, 10mg/kg). Controls (n=18) received the vehicle only. 24 
hours after injection 1ml blood was collected by cardiac puncture. Puncture of the 
suboccipital fossa was performed to collect cerebrospinal fluid (CSF). Methionine metabolites 
were measured by using stable isotope dilution tandem mass spectrometry. Plasma total 
homocysteine and cysteine were measured by HPLC using fluorescence detection. 
Glutathione was assayed by a modified enzymatic microtiter plate assay.  
Results: We observed significantly higher plasma levels of SAM (p<0.001) and of the ratio of 
SAM/SAH (p=0.004) in septic animals. In CSF, septic animals also had higher levels of SAM 
for trend (p=0.067). Oxidative stress was reflected by an increase in the ratio of 
oxidized/reduced glutathione in septic animals (p=0.001). 
Conclusions: Sepsis is associated with an increase in the SAM/SAH ratio in plasma and CSF 
in rodents. This indicates an altered methylation potential during sepsis, which may be 
relevant for sepsis-associated impairment of transmethylation reactions, circulation and 
defence against oxidative stress. If verified in humans such findings could lead to novel 
strategies of supportive treatment of sepsis, as methionine metabolism can easily be 
manipulated by dietary strategies. 
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Introduction  
Despite considerable efforts sepsis is still one of the leading causes of death in intensive care 
units (1, 2). Sepsis markedly alters metabolism, in particular amino acid and protein 
metabolism (3, 4). During transmethylation of methionine to homocysteine, methionine is 
transferred to S-adenosylmethionine (SAM; Fig1). SAM occupies a central position in the 
metabolism of all cells as an essential methyl donor to maintain normal methylation of DNA, 
RNA, proteins, phospholipids, histones and neurotransmitters as well as a multitude of small 
molecules necessary for normal cell function and viability. SAM can control the expression of 
multiple genes in a dose dependent manner by binding to riboswitches that control 
transcription and translation (5). In sepsis SAM inhibits the decrease of circulating immuno-
active cells and the increase of the pro-inflammatory cytokine IL-1 (6). The degradation 
product of SAM is S-adenosylhomocysteine (SAH), which is reversibly hydrolyzed to 
homocysteine (Hcys). Hcys can be transsulfurated into cystathionine via cystathionine beta-
synthase. Further, via cystathionine gamma-lyase, cystathionine is catalyzed to cysteine as 
component of glutathione (GSX), which is important for the cellular redox system. As an 
alternative to transsulfuration, Hcys can be recycled by remethylation to methionine via 
methionine synthase. This requires vitamin B12 and 5-methyltetrahydrofolate (5-MTHF), 
which is synthesized by 5,10-methylenetetrahydrofolate reductase (MTHFR) from 5,10-
methylenetetrahydrofolate (5,10-MTHF). In addition, the latter folate derivate is necessary for 
nucleic acid synthesis. Supraphysiological doses of vitamin B12 and vitamin B2, a cofactor of 
MTHFR, are beneficial in sepsis (7, 8). LPS is a major cell wall constituent of Gram-negative 
bacteria. The LPS-model of sepsis induction works through binding to the LPS-binding 
protein (LBP), endothelial activation through a receptor complex of Toll-like receptor 4 
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(TLR4), the LPS receptor molecule (CD14), and MD2, as well as early activation of nuclear 
factor-κ-B (NF-κB), finally resulting in the production of various pro-inflammatory mediators 
and possibly cell injury (9).  
In view of the central importance of methionine metabolism for overall cellular viability and 
oxidative defence and the beneficial role of cofactors of important enzymes of methionine 
metabolism during sepsis, we aimed at investigating the effects of sepsis on essential 
components of methionine metabolism. We compared the ratios SAM/SAH, oxidized/ 
reduced glutathione (GSSG/GSH) and Hcys and cysteine levels in LPS-treated and control 
rats. The ratio SAM/SAH is important because it is used as an indicator of the cellular 
methylation potential, as SAM and SAH are the substrate and product, respectively, of 
essential methyltransferase reactions, and SAH antagonises effectively SAM-dependent 
transmethylation reactions. The ratio GSSG/GSH is a common measure for the cellular redox 
potential, and the Hcys and cysteine levels are indicative of the transsulfuration activity of the 
methionine metabolism (10). As the involvement of the central nervous system is a common 
complication of sepsis and is associated with a higher mortality in sepsis patients (11, 12), we 
additionally measured SAM and SAH in the CSF. 
 
 
Methods 
Male Wistar rats (Charles River, Germany) weighing 250 – 300 g were housed in groups of 
four under standard conditions at a temperature of 22°C (±1°C) and a 12h light-dark cycle 
with free access to standard food pellets (Altromin, Soest, Germany) and tap water.  
To initiate experimental sepsis, rats received LPS (0127:B8, E. coli (10mg/kg) dissolved in 
1ml sodium chloride (0.9%) intraperitoneally (i.p.; n=22). Control animals received the 
vehicle (sodium chloride) alone (n=18). 24 hours after initiation of experimental sepsis 
animals were anesthetized with ketamine (75 mg/kg) and xylazine hydrochloride (10 mg/kg) 
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i.p. Puncture of the suboccipital fossa was performed to collect approximately 100μl of CSF. 
1ml blood was collected by cardiac puncture and stored in EDTA-containing vials. All 
animals were sacrificed by decapitation. Septic and control animals were treated in parallel in 
groups of 10 each. The animal experiments were approved by the local government. 
To obtain plasma, the blood was centrifuged for 15 min at 4000g and 4ºC, immediately after 
collection. The supernatant was deproteinized by perchloric acid 10%. All aliquots were 
stored at -80ºC for 1-2 months before shipment on dry ice. Deproteinized plasma and CSF 
were used for simultaneous determination of SAM and SAH by using stable isotope dilution 
tandem mass spectrometry as previously published. Inter-assay coefficients of variation were 
6.8% for SAM and 6.9% for SAH (13). Due to the limited amounts of available CSF, we 
restricted CSF analysis to the “key parameters“ SAM and SAH. Plasma total homocysteine 
and cysteine were measured by HPLC using fluorescence detection. Inter-assay coefficients of 
variation for homocysteine and cysteine were 1.8 and 3.6%, respectively (14). Glutathione 
was assayed as total cellular glutathione, i.e. the sum of the reduced and oxidized forms by a 
modified enzymatic microtiter plate assay (15, 16). Briefly, pellets of EDTA blood were 
treated with sulfosalicylic acid prior to centrifugation and freezing of the supernatant. Total 
cellular glutathione content was determined after addition of dithiobisnitrobenzoic acid 
(DTNB) to aliquots of the supernatant at a final concentration of 10mM by absorbance 
changes at 405nm for 10 min. To determine oxidized glutathione, reduced glutathione was 
derivatized with 2.5% 2-vinylpyridine for 60 min prior to kinetic measurement. Protein 
content was determined using the Lowry method (17). Reduced glutathione was calculated 
from the difference of total glutathione and oxidized glutathione. 
 
Statistics 
Differences between groups were calculated with the two-sided t-test, and correlation analysis 
was performed using the Pearson's correlation coefficient. A p-value of ≤0.05 was considered 
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statistically significant.  
 
Results 
Experimental induction of sepsis led to typical symptoms such as piloerection, tachypnoea 
and social withdrawal. One rat of the sepsis group died during the observation period. All 
other rats survived LPS and vehicle treatment. Thus, groups of LPS-treated versus control 
animals included 21 and 18 rats, respectively.  
The plasma and CSF results are listed in Table 1. In the LPS-treated rats, the plasma 
SAM/SAH-ratio was significantly higher (p=0.004) than in the control animals due to higher 
SAM levels (p<0.001). Comparable, but not significantly different results were obtained for 
the changes of SAM (p=0.067) and SAH levels in CSF. SAM in plasma and SAM in CSF 
correlated significantly both in septic animals (r = 0.460; p = 0.041) as well as in controls (r = 
0.691; p = 0.006). There was no significant difference between Hcys and cysteine between 
both groups. The levels of total glutathione did not significantly differ, either. However, the 
relative amount of oxidized glutathione (GSSG) was significantly higher (p=0.022), and 
reduced glutathione (GSH) was significantly lower (p<0.001), and consecutively, the ratio 
oxidized/reduced glutathione was significantly higher (p=0.001) in septic animals.  
In explorative analysis in septic animals we found a correlation between plasma Hcys and 
SAH levels (r = 0.601; p = 0.011), between Hcys plasma and total cellular glutathione blood 
levels (r = 0.633; p = 0.011), and, for trend, between SAM plasma and total cellular 
glutathione blood levels (r = 0.434; p = 0.064).  
 
Discussion 
Protein metabolism is markedly changed during sepsis, characterized by a generalized protein 
catabolism in the muscle accompanied by an enhanced elimination of amino acids from the 
intravascular space mainly to the liver (3, 18). Proteolysis might contribute to the observed 
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increase in SAM. SAM is the universal methyl donor for all methyltransferases. Sepsis-
induced inhibition of these methyltransferases may lead to impaired utilisation of SAM and 
contribute to the rise in SAM-levels. Increased Hcys-remethylation to methionine and finally 
SAM during sepsis is unlikely, as oxidative stress leads to decreased activities of methionine 
synthase and betaine-homocysteine S-methyltransferase (19-21). In addition, we would expect 
Hcys levels to be lower in septic animals in the case of increased remethylation during sepsis. 
Also, high SAM levels down-regulate MTHFR, a key enzyme in Hcys-remethylation, making 
it unlikely that remethylation is increased (22). Finally, the increase of SAM might be due to 
an enhanced synthesis of SAM from methionine during sepsis. The present data do not allow 
any conclusion on the underlying mechanism.   
Because SAM and SAH are the substrate and product of essential methyltransferase reactions, 
and because SAH is an effective antagonist of transmethylation enzymes, the ratio of 
SAM/SAH is frequently used as an indicator of the cellular methylation potential (23, 24). 
The ratio of SAM/SAH of 6.55 found in the controls in the current study corresponds well to 
the SAM/SAH ratios found in humans in former studies under physiological conditions (24, 
25). However, this ratio augments during sepsis indicating an increased methylation potential, 
which will influence numerous reactions involved in cellular metabolism, DNA methylation, 
membrane stability and neurotransmitter synthesis (26-28).  
In the CSF of septic rats we also observed increased SAM levels and an increased ratio of 
SAM/SAH for trend. SAM in plasma and in CSF correlated in controls and after LPS 
treatment, suggesting that measurement of SAM in the plasma is suited to determine SAM 
availability in the CNS under physiological conditions as well as during sepsis. 
 
Glutathione is one of the most important cellular redox systems, and oxidative stress was 
found to play a key role in various diseases including sepsis (29-33). During sepsis the 
amount of oxidized glutathione increased, the amount of reduced glutathione decreased, and, 
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consecutively, the ratio of oxidized/reduced glutathione increased indicating relevant 
oxidative stress during sepsis. In the liver about 50% of the cysteine in glutathione is derived 
from homocysteine via the transsulfuration pathway (34). The positive correlation between 
Hcys and glutathione during sepsis, but not in controls, suggests that Hcys is required for 
production of glutathione during sepsis (Fig1). 
Transsulfuration is enhanced by high SAM levels, as SAM physiologically activates 
cystathionine beta-synthase (CBS) and lowers MTHFR activity (10, 22). Accordingly, we 
found an increase in Hcys and cysteine levels for trend. Thus, the observed data indicate that 
the higher levels of SAM lead to a higher production of Hcys and to a higher transsulfuration 
rate of Hcys to allow the synthesis of glutathione for defence of oxidative stress induced by 
sepsis.  In addition to that, oxidative stress leads to increased flux of Hcys through the 
transsulfuration pathway by up-regulation of CBS activity (35) and decreased activities of 
methionin synthase and betaine-homocysteine S-methyltransferase (19-21). Increased 
transulfuration rates during experimentally induced sepsis were also shown by injections of 
radiolabeled cysteine and methionine in rats (36, 37). 
Methionine metabolism is markedly altered during LPS-induced sepsis in rodents. The 
validity of our data is limited as the LPS-model of sepsis does not accurately reflect human 
sepsis (38). Further, blood and CSF samples were taken at one point of time only. However, 
the observed data encourage future studies that measure metabolites of methionine 
metabolism in human patients over time to explore the association of sepsis with methionine 
metabolism in more detail. As methionine metabolism can easily be manipulated by dietary 
strategies like supplementation of vitamins or SAM, such studies could lead to strategies of 
additive treatment of sepsis.  
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Table 1. Comparison of LPS-treated and control animals. 
 
Parameter control rats 
(n = 18) 
mean ± 1SD 
LPS-treated rats 
(n = 21) 
t-Test (two-sided)  
SAM (nmol/L)  178.6 ± 33.8 367.2 ± 152.0 p < 0.001 
SAH (nmol/L)  39.32 ± 25.6 41.20 ± 28.0 p = 0.832 
SAM/SAH ratio 6.55 ± 3.74 11.90 ± 6.39 p = 0.004 
CSF: SAM (nmol/L) 324.09 ± 159.67 420.64 ± 141.37 p = 0.067 
CSF: SAH (nmol/L) 25.14 ± 25.65 22.05 ± 21.62 p = 0.702 
CSF: SAM/SAH 20.17 ± 11.20 29.87 ± 17.35 p = 0.068 
Hcys (μmol/L) 2.78 ± 0.81 4.44 ± 2.62 p = 0.063 
cysteine (μmol/L) 178 ± 15 218 ± 52 p = 0.093 
GSH (nmol/mg protein) 216.57 ± 70.0 102.55 ± 38.46 p < 0.001 
GSSG (nmol/mg protein) 59.67 ± 58.36 117.79 ± 77.46 p = 0.022 
GSSG/GSH 0.24 ± 0.17 0.48 ± 0.09 p = 0.001 
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FAD
NADPH 
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methionine
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folate
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